🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study was to assess whether sofosbuvir in combination with ribavirin (...
Status
Completed
Location
University of Alabama Birmingham
Start Date
2012-06
Trial ID
NCT01641640
Treatments Being Tested
This study will evaluate the efficacy and safety of NEUTRINO regimen in Chi...
Status
Completed
Location
Liver Fibrosis Diagnosis and Treatment Centre, 302 Hospital
Start Date
2015-01
Trial ID
NCT02480686
Treatments Being Tested
The purpose of this study is to evaluate if a 12-week total regimen of tela...
Status
Terminated
Location
Multiple Locations
Start Date
2011-11
Trial ID
NCT01459913
Treatments Being Tested
The purpose of this study is to determine the safety, efficacy and tolerabi...
Status
Completed
Location
Multiple Locations
Start Date
2008-10
Trial ID
NCT00703118
Treatments Being Tested
The purpose of this study is to evaluate the impact of a physician directed...
Status
Completed
Location
California Liver Institute
Start Date
2011-12
Trial ID
NCT01405027
Treatments Being Tested
The purpose of this study is to evaluate the effectiveness of telaprevir in...
Status
Completed
Location
Multiple Locations
Start Date
2012-02
Trial ID
NCT01571583
Treatments Being Tested
To assess efficacy of telaprevir, pegylated interferon alfa-2a (Peg-IFN-alf...
Status
Terminated
Location
Alabama
Start Date
2012-02
Trial ID
NCT01467505
Treatments Being Tested
To provide access to a telaprevir-based treatment to subjects of the Contro...
Status
Completed
Location
Multiple Locations
Start Date
2007-10
Trial ID
NCT00535847
Treatments Being Tested
The current Standard of Care (SOC) for chronic HCV infection, which is pegy...
Status
Completed
Location
1220.14.003 Boehringer Ingelheim Investigational Site
Start Date
2009-07
Trial ID
NCT00947349
This will be a randomized, open-label, active-control Phase II pilot trial ...
Status
Completed
Location
LTD Vakhtang Bochorishvili Anticeptic Centre
Start Date
2011-01
Trial ID
NCT01273948
Treatments Being Tested